NHC vs. VRTX
Compare and contrast key facts about National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NHC or VRTX.
Correlation
The correlation between NHC and VRTX is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NHC vs. VRTX - Performance Comparison
Key characteristics
NHC:
0.58
VRTX:
0.03
NHC:
1.00
VRTX:
0.19
NHC:
1.12
VRTX:
1.03
NHC:
0.90
VRTX:
0.03
NHC:
2.25
VRTX:
0.10
NHC:
7.43%
VRTX:
6.93%
NHC:
28.70%
VRTX:
24.40%
NHC:
-94.71%
VRTX:
-91.77%
NHC:
-18.44%
VRTX:
-21.01%
Fundamentals
NHC:
$1.90B
VRTX:
$120.84B
NHC:
$7.99
VRTX:
-$1.88
NHC:
0.00
VRTX:
1.23
NHC:
$1.23B
VRTX:
$10.61B
NHC:
$466.33M
VRTX:
$9.14B
NHC:
$211.17M
VRTX:
$517.70M
Returns By Period
In the year-to-date period, NHC achieves a 22.49% return, which is significantly higher than VRTX's 0.32% return. Over the past 10 years, NHC has underperformed VRTX with an annualized return of 8.78%, while VRTX has yielded a comparatively higher 13.21% annualized return.
NHC
22.49%
-12.01%
5.26%
16.73%
8.99%
8.78%
VRTX
0.32%
-9.49%
-13.85%
0.72%
13.17%
13.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NHC vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NHC vs. VRTX - Dividend Comparison
NHC's dividend yield for the trailing twelve months is around 2.16%, while VRTX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NHC National HealthCare Corporation | 2.16% | 2.53% | 3.80% | 3.11% | 3.13% | 2.38% | 2.52% | 3.10% | 2.31% | 3.14% | 2.13% | 2.34% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NHC vs. VRTX - Drawdown Comparison
The maximum NHC drawdown since its inception was -94.71%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for NHC and VRTX. For additional features, visit the drawdowns tool.
Volatility
NHC vs. VRTX - Volatility Comparison
The current volatility for National HealthCare Corporation (NHC) is 7.37%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 14.20%. This indicates that NHC experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NHC vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between National HealthCare Corporation and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities